Travelers can now purchase the only once-weekly, broad-spectrum malaria preventive online, through the Runway Health ...

Car-T cell therapy is “borrowed” from cancer treatment. Image in Creative Commons. A 47-year-old woman in Germany had spent ...

A patient with three different autoimmune diseases has entered complete remission after undergoing an experimental treatment ...

For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...

A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...

Beta thalassemia minor is a blood disorder that can cause mild anemia, but it often doesn't show symptoms. If both parents carry the trait for beta thalassemia minor, there's a higher risk of having a ...

Currently no FDA-approved therapies are available for wAIHA, a rare, heterogeneous, life-threatening disease in which pathogenic immunoglobulin (IgG) autoantibodies attach to and destroy red blood ...

"People living with warm autoimmune hemolytic anemia face a serious, life-threatening disease with no approved treatment options and a high risk of complications, including profound chronic fatigue, ...

Phase 2b LUMINA 2 study data support rilzabrutinib's FDA Breakthrough Therapy designation for the treatment of warm autoimmune hemolytic anemia. The Food and Drug Administration (FDA) has granted ...

1. In this prospective cohort study, CD19-directed chimeric antigen receptor (CAR) T-cell therapy was found to elicit a complete response in eleven patients with autoimmune hemolytic anemia who had ...